FDA approves Ligand Partner SQ Innovation’s Lasix ONYU for heart failure edema—at-home use marks major shift in care
Find out how Ligand and SQ Innovation’s FDA-approved Lasix ONYU is redefining heart-failure treatment with the first at-home edema therapy. Read More
Axon Therapies bags $32m to push heart failure trials—can this MedTech deliver where drugs failed?
Axon Therapies raises $32M to advance implant-free heart failure therapy. Learn how its splanchnic ablation trials could reshape cardiology. Read More
Can real-time blood-volume monitoring finally cut heart failure readmissions?
Discover how FDA-cleared blood-volume monitoring devices like Daxor’s could help hospitals reduce costly heart failure readmissions. Read More
Daxor wins FDA clearance for handheld blood-volume analyzer built with U.S. Department of Defense
Daxor secures FDA clearance for its rapid handheld blood-volume analyzer. Find out how this innovation could reshape heart failure and critical care. Read More
Alkem Laboratories’ latest drug launch promises relief for millions of diabetics in India
Alkem Laboratories Limited has launched its generic version of empagliflozin and its combinations in India under the brand name Empanorm, offering a significant price reduction ... Read More
Aeson total artificial heart shows promise for heart failure patients with pulmonary hypertension
A significant advancement in pulmonary hypertension treatment for heart failure patients has emerged with the latest study on the Aeson total artificial heart. Published in ... Read More
Johnson & Johnson to acquire V-Wave Ltd. in $1.1bn deal to enhance heart failure treatment
Johnson & Johnson (NYSE: JNJ) has made headlines with its decision to acquire V-Wave Ltd., a private company renowned for its cutting-edge treatments for heart ... Read More
Bayer announces start of Phase 2 GenePHIT trial for AB-1002
Bayer AG and its subsidiary Asklepios BioPharmaceutical, Inc. (AskBio), have achieved a significant milestone in the fight against congestive heart failure (CHF) with the randomization ... Read More
Zydus Lifesciences announces FDA approval for heart failure drug, Ivabradine Tablets
Zydus Lifesciences Limited, a significant player in the pharmaceutical industry, has received final approval from the United States Food and Drug Administration (FDA) for its ... Read More
WhiteSwell’s eLym System shows promise in acute decompensated heart failure treatment
WhiteSwell, a frontrunner in the treatment of acute decompensated heart failure (ADHF), has shared optimistic initial results from its continuing DELTA-HF trial centered around the ... Read More